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LETTER TO THE EDITOR

Time for Reintroducing HPV
Vaccine in Pakistan for
Primary Prevention of Cervical
Cancer
Sir,
Human papilloma virus (HPV) vaccination is an eﬀective prevention against cervical cancer, the 4th leading cancer among
women worldwide. Global cervical cancer elimination is a WHO
2030 target where one key strategy is reaching a global target
of 90% of girls being vaccinated with HPV vaccine by 15 years of
1
age. Since the HPV vaccine approval by the FDA back in 2006,
more than 80 countries have introduced the HPV vaccine.
Australia is going to be the ﬁrst country to achieve cervical
cancer elimination by 2035 through their National Immunization Program, providing free of cost HPV vaccine to school-going
boys and girls.2 With the introduction of three licensed and safe
HPV vaccines,3 HPV vaccines programs are also being implemented successfully in low-to-middle income countries like
India, Bhutan, Malaysia, Indonesia, and Bangladesh where the
vaccines are usually available at doctor oﬃces, community
health clinics, school-based health centres, and health departments.4
HPV vaccine was introduced 3-4 years back in Pakistan, but no
data is available for its coverage and reasons for discontinuation. Unfortunately, there is no HPV vaccine currently available
in most parts of Pakistan or any HPV vaccination program,
making HPV a major threat to 68.6 million women at risk. In a
prediction model study, up to 133,000 cervical cancer cases
would be prevented over the next decade with 90% annual HPV
immunisation coverage among girls.5 Pakistan needs to reintroduce HPV vaccine preferably at a national level, utilising routine
eﬀective and established immunisation delivery strategies.
The government of Sindh, Pakistan has announced that they will
be launching HPV vaccination program for adolescent girls
(school-based) in Karachi in 2022.6 Before the vaccine rollout, it
is important to increase awareness about the use and safety of
HPV vaccine while dispelling misinformation about it.
Programmatic challenges and HPV vaccine resistance due to
multiple factors particularly in reaching this new target of the
school age group for routine vaccination are important to
address for the successful implementation of HPV vaccine in
Pakistan. Therefore, it is important to assess awareness, feasibility, and acceptability of the HPV vaccination program among
the general population, health workers and community-level
stakeholders. Nationwide educational campaigns are needed
to increase public, patient and health care professionals' awareness about HPV vaccine. At the same time, the issues of the cost
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of the vaccine and suﬃcient HPV vaccine supplies can be
addressed through working with forums such as GAVI, the
vaccine alliance. The introduction of HPV vaccines will reduce
the risk of cervical cancer, but implementation of screening
programs at the primary health care level in Pakistan remains
important secondary intervention. Despite the global disruption and competing demands from the COVID-19 pandemic,
strong political will and leadership can make a national HPV
vaccination program a reality in Pakistan and get it well on its
way to eliminate a largely preventable cancer in women.
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